checkAd

     1207  0 Kommentare TiGenix appoints Chief Medical Officer and Vice President Medical Affairs and New Product Commercialisation - Seite 3



    This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
    The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
    Source: TiGenix via Globenewswire

    Lesen Sie auch

    HUG#1852621

    GlobeNewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren
    Seite 3 von 3

    Verfasst von GlobeNewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    TiGenix appoints Chief Medical Officer and Vice President Medical Affairs and New Product Commercialisation - Seite 3 1 September, 2014 -TiGenix NV (Euronext Brussels: TIG), an advanced biopharmaceutical company focused on developing and commercialising novel therapeutics from its proprietary platform of allogeneic, expanded adipose-derived stem cells, or eASC's, …

    Auch bei Lesern beliebt

    Schreibe Deinen Kommentar

    Disclaimer